CaPtivat Pharmaceuticals LLC is a privately-owned small biotechnology company focused on developing its proprietary calcium phosphate nanoparticle vaccine adjuvant and delivery platform for applications in human or veterinary health. The technology enables formulation of variety of vaccine antigens CaPtivaX^TM) or therapeutic drugs (CaPteraX^TM) for parenteral or mucosal administration and for prophylactic or therapeutic use, as it indicates capacity to induce T-cell activation. 

In addition to our internal vaccine/drug development programs, we make our nanoparticle technology and formulation services available to interested partners who may be searching for a safe and effective vaccine adjuvant and delivery system to develop novel vaccine formulations against life threatening diseases.